Alphabet’s Life Sciences division partners with Sanofi, leading maker of diabetes medication
According to a new report from The Wall Street Journal, Google’s (now Alphabet’s) Life Sciences is adding another company to a growing list of partners that are helping the group explore new technologies for disease treatment and prevention. Specifically, the Life Sciences group, led by the to-be-CEO Andrew Conrad under Alphabet, has agreed to work with European pharmaceutical company Sanofi on new ways to treat and monitor diabetes…
Expand
Expanding
Close
